Fast versus slow infusion of 20% albumin: a randomized controlled cross-over trial in volunteers.

Markus ZdolsekFolke SjöbergRobert G Hahn

Published in: Intensive care medicine experimental (2022)

The intravascular persistence of albumin was longer, but the fluid kinetics was the same, when 20% albumin was infused over 30 min compared with 120 min. We found no disadvantages of administering the albumin at the higher rate. Trial registration EU Clinical Trials Register, EudraCT2017-003687-12, registered September 22, 2017, https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-003687-12/SE.

Keyphrases

clinical trial
phase iii
phase ii
study protocol
open label
randomized controlled trial
low dose
coronary artery